Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1956 1
1958 1
1959 3
1960 1
1961 1
1962 1
1964 1
1965 2
1966 2
1967 5
1968 6
1969 3
1970 3
1971 3
1972 3
1973 4
1974 3
1975 4
1976 6
1977 2
1978 2
1979 4
1980 4
1982 4
1983 1
1984 3
1985 1
1986 2
1987 4
1988 2
1990 1
1991 4
1992 1
1993 2
1994 3
1995 3
1997 2
1998 1
1999 1
2000 1
2003 3
2004 1
2005 2
2006 4
2008 5
2009 1
2011 5
2012 1
2013 2
2014 1
2015 3
2016 4
2019 2
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

135 results
Results by year
Filters applied: . Clear all
Page 1
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial.
Robson M, Ruddy KJ, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Li W, Tung N, Armstrong A, Delaloge S, Bannister W, Goessl C, Degboe A, Hettle R, Conte P. Robson M, et al. Among authors: bannister w. Eur J Cancer. 2019 Oct;120:20-30. doi: 10.1016/j.ejca.2019.06.023. Epub 2019 Aug 22. Eur J Cancer. 2019. PMID: 31446213 Free PMC article. Clinical Trial.
The EuroSIDA study: Regional differences in the HIV-1 epidemic and treatment response to antiretroviral therapy among HIV-infected patients across Europe--a review of published results.
Podlekareva D, Bannister W, Mocroft A, Abrosimova L, Karpov I, Lundgren JD, Kirk O; EuroSIDA Study Group. Podlekareva D, et al. Among authors: bannister w. Cent Eur J Public Health. 2008 Sep;16(3):99-105. doi: 10.21101/cejph.a3490. Cent Eur J Public Health. 2008. PMID: 18935770 Review.
Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment.
Rolfo C, de Vos-Geelen J, Isambert N, Molife LR, Schellens JHM, De Grève J, Dirix L, Grundtvig-Sørensen P, Jerusalem G, Leunen K, Mau-Sørensen M, Plummer R, Learoyd M, Bannister W, Fielding A, Ravaud A. Rolfo C, et al. Among authors: bannister w. Clin Pharmacokinet. 2019 Sep;58(9):1165-1174. doi: 10.1007/s40262-019-00754-4. Clin Pharmacokinet. 2019. PMID: 30877569 Clinical Trial.
Obstetrical anesthesia.
BANNISTER WK. BANNISTER WK. Trans N Engl Obstet Gynecol Soc. 1958;12:115-25; discussion 126-7. Trans N Engl Obstet Gynecol Soc. 1958. PMID: 13676121 No abstract available.
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment.
Rolfo C, Isambert N, Italiano A, Molife LR, Schellens JHM, Blay JY, Decaens T, Kristeleit R, Rosmorduc O, Demlova R, Lee MA, Ravaud A, Kopeckova K, Learoyd M, Bannister W, Locker G, de Vos-Geelen J. Rolfo C, et al. Among authors: bannister w. Br J Clin Pharmacol. 2020 Sep;86(9):1807-1818. doi: 10.1111/bcp.14283. Epub 2020 Apr 5. Br J Clin Pharmacol. 2020. PMID: 32227355 Free PMC article.
Economic value of a cancer case management program.
Wu C, Bannister W, Schumacker P, Rosen M, Ozminkowski R, Rossof A. Wu C, et al. Among authors: bannister w. J Oncol Pract. 2014 May;10(3):178-86. doi: 10.1200/JOP.2014.001384. J Oncol Pract. 2014. PMID: 24839277
135 results